132 related articles for article (PubMed ID: 35157912)
21. Schisandrin B Induced ROS-Mediated Autophagy and Th1/Th2 Imbalance
Tan S; Zheng Z; Liu T; Yao X; Yu M; Ji Y
Front Immunol; 2022; 13():857069. PubMed ID: 35419003
[TBL] [Abstract][Full Text] [Related]
22. Borneol-Modified Schisandrin B Micelles Cross the Blood-Brain Barrier To Treat Alzheimer's Disease in Aged Mice.
Li FR; Yu Y; Du YM; Kong L; Liu Y; Wang JH; Chen MH; Liu M; Zhang ZX; Li XT; Ju RJ
ACS Chem Neurosci; 2024 Feb; 15(3):593-607. PubMed ID: 38214579
[No Abstract] [Full Text] [Related]
23. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
[TBL] [Abstract][Full Text] [Related]
24. Schisandrin B inhibits the proliferation and invasion of glioma cells by regulating the HOTAIR-micoRNA-125a-mTOR pathway.
Jiang Y; Zhang Q; Bao J; Du C; Wang J; Tong Q; Liu C
Neuroreport; 2017 Jan; 28(2):93-100. PubMed ID: 27977512
[TBL] [Abstract][Full Text] [Related]
25. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.
Xu Y; Liu Z; Sun J; Pan Q; Sun F; Yan Z; Hu X
PLoS One; 2011; 6(12):e28335. PubMed ID: 22164272
[TBL] [Abstract][Full Text] [Related]
26. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q
Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis.
Jing M; Bi XJ; Yao XM; Cai F; Liu JJ; Fu M; Kong L; Liu XZ; Zhang L; He SY; Jia LQ; Li XT
Drug Dev Ind Pharm; 2020 Apr; 46(4):621-634. PubMed ID: 32162988
[TBL] [Abstract][Full Text] [Related]
28. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Life Sci; 2008 May; 82(21-22):1092-101. PubMed ID: 18452952
[TBL] [Abstract][Full Text] [Related]
29. Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor β1.
Wu J; Jia J; Liu L; Yang F; Fan Y; Zhang S; Yan D; Bu R; Li G; Gao Y; Chen Y
J Am Soc Hypertens; 2017 Mar; 11(3):148-157.e1. PubMed ID: 28117274
[TBL] [Abstract][Full Text] [Related]
30. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
[TBL] [Abstract][Full Text] [Related]
31. Schisandrin B attenuates CCl
Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
[TBL] [Abstract][Full Text] [Related]
32. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q
Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569
[TBL] [Abstract][Full Text] [Related]
33. Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats.
Yim TK; Ko KM
Biochem Pharmacol; 1999 Jan; 57(1):77-81. PubMed ID: 9920287
[TBL] [Abstract][Full Text] [Related]
34. Lentivirus-mediated shRNA targeting of cyclin D1 enhances the chemosensitivity of human gastric cancer to 5-fluorouracil.
Seo JH; Jeong ES; Lee KS; Heo SH; Jeong DG; Choi YK
Int J Oncol; 2013 Dec; 43(6):2007-14. PubMed ID: 24100731
[TBL] [Abstract][Full Text] [Related]
35. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
[TBL] [Abstract][Full Text] [Related]
36. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
[TBL] [Abstract][Full Text] [Related]
37. Schisandrin B suppresses glioma cell metastasis mediated by inhibition of mTOR/MMP-9 signal pathway.
Jiang Y; Zhang Q; Bao J; Du C; Wang J; Tong Q; Liu C
Biomed Pharmacother; 2015 Aug; 74():77-82. PubMed ID: 26349966
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
39. Differential Action between Schisandrin A and Schisandrin B in Eliciting an Anti-Inflammatory Action: The Depletion of Reduced Glutathione and the Induction of an Antioxidant Response.
Leong PK; Wong HS; Chen J; Chan WM; Leung HY; Ko KM
PLoS One; 2016; 11(5):e0155879. PubMed ID: 27195753
[TBL] [Abstract][Full Text] [Related]
40. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and associated changes in the Ca(2+)-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Phytother Res; 2009 Nov; 23(11):1592-602. PubMed ID: 19370538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
